Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancers|October 27, 2022
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging DemandJuan Morote, Ángel Borque-Fernando, Marina Triquell, et al.
Cancers|September 28, 2023
A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic BiopsiesJuan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, et al.
Urologic Oncology|May 27, 2023
Are magnetic resonance imaging and targeted biopsies needed in men with serum prostate-specific antigen over 10 ng/ml and an abnormal digital rectal examination?Juan Morote, Natàlia Picola, Nahuel Paesano, et al.
Cancers|April 12, 2022
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate CancerJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
Urologic Oncology|November 8, 2020
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findingsJuan Morote, Iván Schwartzman, Angel Borque, et al.
Cancers|May 28, 2022
Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate BiopsyJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
Urologic Oncology|February 11, 2024
Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in CataloniaJuan Morote, Ángel Borque-Fernando, Luis E Esteban, et al.
Cancers|March 25, 2022
The Barcelona Predictive Model of Clinically Significant Prostate CancerJuan Morote, Angel Borque-Fernando, Marina Triquell, et al.
BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.
Pageof 2